B-type natriuretic peptide is related to left ventricular mass in hypertensive patients but not in athletes

被引:31
作者
Almeida, SS [1 ]
Azevedo, A [1 ]
Castro, A [1 ]
Frioes, F [1 ]
Freitas, J [1 ]
Ferreira, A [1 ]
Bettencourt, P [1 ]
机构
[1] Univ Porto, Fac Med, Dept Med, Hosp S Joao,Unidade Invest & Desenvolvimento Card, P-4100 Oporto, Portugal
关键词
athletes; B-type natriuretic peptide; left ventricular mass; ventricular geometry;
D O I
10.1159/000066319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A positive correlation has been previously documented between B-type natriuretic peptide (BNP) levels and left ventricular mass index (LVMI) in hypertensive patients. We evaluated 8 cycling athletes, 8 healthy age-matched controls; 17 hypertensive patients and 7 age-matched controls. LVMI was significantly higher in athletes and hypertensive patients than in their controls. Plasma levels of BNP in hypertensive patients were significantly higher than in athletes and their age-matched controls. No significant difference was found between athletes and their controls. Cycling athletes had significantly larger LVMI than hypertensive patients and controls, without elevated BNP levels. These results suggest that BNP levels are elevated in patients with increased LVM due to hypertension but not in physiologically increased LVM. Whether elevated BNP levels in athletes is a sign of structural heart disease merits further investigation. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:113 / 115
页数:3
相关论文
共 11 条
[1]   Predictors of prognosis in patients with stable mild to moderate heart failure [J].
Bettencourt, P ;
Ferreira, A ;
Dias, P ;
Pimenta, J ;
Frioes, F ;
Martins, L ;
Cerqueira-Gomes, M .
JOURNAL OF CARDIAC FAILURE, 2000, 6 (04) :306-313
[2]   Brain natriuretic peptide as a marker of cardiac involvement in hypertension [J].
Bettencourt, P ;
Ferreira, A ;
Sousa, T ;
Ribeiro, L ;
Brandao, F ;
Polónia, J ;
Cerqueira-Gomes, M ;
Martins, L .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 69 (02) :169-177
[3]  
Cubero GI, 2000, INT J CARDIOL, V75, P261
[4]  
Fagard Robert H., 1997, Cardiology Clinics, V15, P397
[5]   BRAIN NATRIURETIC PEPTIDE AS A CARDIAC HORMONE IN ESSENTIAL-HYPERTENSION [J].
KOHNO, M ;
HORIO, T ;
YOKOKAWA, K ;
MURAKAWA, KI ;
YASUNARI, K ;
AKIOKA, K ;
TAHARA, A ;
TODA, I ;
TAKEUCHI, K ;
KURIHARA, N ;
TAKEDA, T .
AMERICAN JOURNAL OF MEDICINE, 1992, 92 (01) :29-34
[6]   Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy [J].
Kozàkovà, M ;
Galetta, F ;
Gregorini, L ;
Bigalli, G ;
Franzoni, F ;
Giusti, C ;
Palolmbo, C .
HYPERTENSION, 2000, 36 (03) :343-349
[7]   Biochemical detection of left-ventricular systolic dysfunction [J].
McDonagh, TA ;
Robb, SD ;
Murdoch, DR ;
Morton, JJ ;
Ford, I ;
Morrison, CE ;
Tunstall-Pedoe, H ;
McMurray, JJV ;
Dargie, HJ .
LANCET, 1998, 351 (9095) :9-13
[8]  
Pluim BM, 1996, EUR HEART J, V17, P1271
[9]   Changes in cardiac markers including B-natriuretic peptide in runners after the Boston marathon [J].
Siegel, AJ ;
Lewandrowski, EL ;
Chun, KY ;
Sholar, MB ;
Fischman, AJ ;
Lewandrowski, KB .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (08) :920-+
[10]   Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy [J].
Yamamoto, K ;
Burnett, JC ;
Jougasaki, M ;
Nishimura, RA ;
Bailey, KR ;
Saito, Y ;
Nakao, K ;
Redfield, MM .
HYPERTENSION, 1996, 28 (06) :988-994